About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exact Sciences Launches New Spanish-Language Campaign to Increase Colon Cancer Screening in Hispanic Community

By: Brandpoint

(BPT) - The facts around colon cancer, also known as colorectal cancer, are too staggering to ignore. It is the second leading cause of cancer-related death in the United States.1

Yet despite recommendations, less than half (49%) of eligible Hispanic adults - there are currently over 17 million Hispanic people in the U.S. over the age of 45 - undergo recommended screening.2,3 Barriers to screening include language and cultural differences as well as lack of access, but the biggest reason may be that people don't realize that colon cancer screening should start at age 45.

To help increase awareness around colon cancer screening, Exact Sciences has launched its first-ever Spanish-language campaign tailored to the Hispanic community timed to Hispanic Heritage Month. The campaign, which will appear on television, radio and social media, includes important information about the Cologuard® test - a non-invasive, effective and affordable at-home colon cancer screening test.

Early detection of colon cancer before a person has symptoms arise can significantly improve treatment options and survival rates.4 The American Cancer Society recommends that anyone at average risk and aged 45+ get screened.4 When found at an early stage, the 5-year relative survival rate is close to 90%. However, if the cancer is not caught before it spreads to distant parts of the body, that survival rate drops to around 14%.5

'Education and early screening are vital in catching this disease early and improving outcomes,' said Veronica Descotte, Chief Strategy Officer at Exact Sciences. 'Our goal is to ensure that everyone, particularly in the Hispanic community, has access to the information and resources they need.'

One Patient's Story

Colon cancer survivor and advocate, Marielle, noticed troubling health symptoms back in 2017. It started with blood in her stool, then stomach pain, and, eventually, sudden weight loss of 20 pounds in just a few weeks. Despite her concerns, the medical advice she received didn't lead to answers. It wasn't until she pushed her doctor for further testing that the 36-year-old Latina discovered she had colon cancer.

'I think many people in my community would be surprised to know that colon cancer can be fully cured in early stages and even prevented through the removal of growths called polyps,' said Marielle, Director of Programs & Advocacy at a national peer support organization. 'The reality is that it's not always possible to take time off from work to get into the doctor's office. Having convenient and non-invasive options for testing that can be done in the privacy of your own home is a game changer.'

Marielle and her familly posing by a fountain.
Photo courtesy Marielle, colon cancer survivor and advocate.

A Call to Action

As we look to the future, the efforts of organizations like Exact Sciences and advocates like Marielle aim to create a world where colon cancer is detected earlier, treated more effectively, and ultimately prevented.

If you're 45 or older, talk to your doctor about available colon cancer screening options that are right for you. Learn more by visiting www.cologuard.com.

The Cologuard test is intended to screen adults 45 years of age and older who are at average risk for colorectal cancer by detecting certain DNA markers and blood in the stool. Do not use if you have had adenomas, have inflammatory bowel disease and certain hereditary syndromes, or a personal or family history of colorectal cancer. A Cologuard test is not a replacement for colonoscopy in high-risk patients. Cologuard test performance in adults ages 45-49 is estimated based on a large clinical study of patients 50 and older.

The Cologuard test result should be interpreted with caution. A positive test result does not confirm the presence of cancer. Patients with a positive test result should be referred for colonoscopy. A negative test result does not confirm the absence of cancer. Patients with a negative test result should discuss with their doctor when they need to be tested again. False positives and false negative results can occur. In a clinical study, 13% of people without cancer received a positive result (false positive) and 8% of people with cancer received a negative result (false negative). Rx only.

Top photo courtesy Exact Sciences

REFERENCES

  1. National Cancer Institute. Cancer Stat Facts: Common Cancer Sites. 2024.
  2. American Cancer Society. Cancer Facts & Figures for Hispanic/Latino People 2021-2023. 2021.
  3. U.S. Census. Annual Estimates of the Resident Population by Sex, Age, Race, and Hispanic Origin of the United States: April 1, 2020 to July 1, 2023. 2020.
  5. Colon Cancer Coalition. Get the Facts About Colon Cancer. 2024.

More News

View More
3 Heavily Shorted Stocks That Could Pop on Rate Cuts
Via MarketBeat
Topics Artificial Intelligence Economy
Tickers ETSY SMR SOUN
Broadcom Gets Second $420 Target as CPO Win Boosts Outlook
Via MarketBeat
Tickers AVGO META
PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can
Via MarketBeat
Tickers PEP
Bargain Alert: DraftKings Is the Most Oversold It’s Ever Been
Via MarketBeat
Tickers DKNG
Constellation Brands: Buffett’s $2.2B Bet May Have Hit Bottom
Via MarketBeat
Tickers BUD STZ
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.